Cinaciguat Prevents Postnatal Closure of Ductus Arteriosus by Vasodilation and Anti-remodeling in Neonatal Rats

Closure of the ductus arteriosus (DA) involves vasoconstriction and vascular remodeling. Cinaciguat, a soluble guanylyl cyclase (sGC) activator, was reported with vasodilatory and anti-remodeling effects on pulmonary hypertensive vessels. However, its effects on DA are not understood. Therefore, we...

Full description

Bibliographic Details
Main Authors: Yu-Chi Hung, Yi-Ching Liu, Bin-Nan Wu, Jwu-Lai Yeh, Jong-Hau Hsu
Format: Article
Language:English
Published: Frontiers Media S.A. 2021-07-01
Series:Frontiers in Physiology
Subjects:
Online Access:https://www.frontiersin.org/articles/10.3389/fphys.2021.661171/full
_version_ 1831630058649812992
author Yu-Chi Hung
Yu-Chi Hung
Yi-Ching Liu
Bin-Nan Wu
Bin-Nan Wu
Bin-Nan Wu
Jwu-Lai Yeh
Jwu-Lai Yeh
Jwu-Lai Yeh
Jwu-Lai Yeh
Jong-Hau Hsu
Jong-Hau Hsu
author_facet Yu-Chi Hung
Yu-Chi Hung
Yi-Ching Liu
Bin-Nan Wu
Bin-Nan Wu
Bin-Nan Wu
Jwu-Lai Yeh
Jwu-Lai Yeh
Jwu-Lai Yeh
Jwu-Lai Yeh
Jong-Hau Hsu
Jong-Hau Hsu
author_sort Yu-Chi Hung
collection DOAJ
description Closure of the ductus arteriosus (DA) involves vasoconstriction and vascular remodeling. Cinaciguat, a soluble guanylyl cyclase (sGC) activator, was reported with vasodilatory and anti-remodeling effects on pulmonary hypertensive vessels. However, its effects on DA are not understood. Therefore, we investigated whether cinaciguat regulated DA patency and examined its underlying mechanisms. In vivo, we found that cinaciguat (10 mg/kg, i.p. at birth) prevented DA closure at 2 h after birth with luminal patency and attenuated intimal thickening. These anti-remodeling effects were associated with enhanced expression of cyclic guanosine monophosphate (cGMP) in DA. Ex vivo, cinaciguat dilated oxygen-induced DA constriction dose-dependently. Such vasodilatory effect was blunted by KT-5823, a PKG inhibitor. In DA smooth muscle cells (DASMCs), we further showed that cinaciguat inhibited angiotensin II (Ang II)-induced proliferation and migration of DASMCs. In addition, cinaciguat inhibited Ang II-induced mitochondrial reactive oxygen species (ROS) production. Finally, Ang II-activated MAPKs and Akt were also inhibited by cinaciguat. In conclusion, cinaciguat prevents postnatal DA closure by vasodilation and anti-remodeling through the cGMP/PKG pathway. The mechanisms underlying anti-remodeling effects include anti-proliferation and anti-migration, with attenuation of mitochondrial ROS production, MAPKs, and Akt signaling. Thus, this study implicates that sGC activation may be a promising novel strategy to regulate DA patency.
first_indexed 2024-12-19T02:11:13Z
format Article
id doaj.art-a508a5fd03a546dd98e20f92091e65cb
institution Directory Open Access Journal
issn 1664-042X
language English
last_indexed 2024-12-19T02:11:13Z
publishDate 2021-07-01
publisher Frontiers Media S.A.
record_format Article
series Frontiers in Physiology
spelling doaj.art-a508a5fd03a546dd98e20f92091e65cb2022-12-21T20:40:46ZengFrontiers Media S.A.Frontiers in Physiology1664-042X2021-07-011210.3389/fphys.2021.661171661171Cinaciguat Prevents Postnatal Closure of Ductus Arteriosus by Vasodilation and Anti-remodeling in Neonatal RatsYu-Chi Hung0Yu-Chi Hung1Yi-Ching Liu2Bin-Nan Wu3Bin-Nan Wu4Bin-Nan Wu5Jwu-Lai Yeh6Jwu-Lai Yeh7Jwu-Lai Yeh8Jwu-Lai Yeh9Jong-Hau Hsu10Jong-Hau Hsu11Graduate Institute of Medicine, College of Medicine, Kaohsiung Medical University, Kaohsiung, TaiwanDepartment of Pediatrics, St. Joseph Hospital, Kaohsiung, TaiwanDepartment of Pediatrics, Kaohsiung Medical University Hospital, Kaohsiung Medical University, Kaohsiung, TaiwanGraduate Institute of Medicine, College of Medicine, Kaohsiung Medical University, Kaohsiung, TaiwanDepartment of Pharmacology, College of Medicine, Kaohsiung Medical University, Kaohsiung, TaiwanDepartment of Medical Research, Kaohsiung Medical University, Kaohsiung, TaiwanGraduate Institute of Medicine, College of Medicine, Kaohsiung Medical University, Kaohsiung, TaiwanDepartment of Pharmacology, College of Medicine, Kaohsiung Medical University, Kaohsiung, TaiwanDepartment of Medical Research, Kaohsiung Medical University, Kaohsiung, TaiwanDepartment of Marine Biotechnology and Resources, National Sun Yat-sen University, Kaohsiung, TaiwanDepartment of Pediatrics, Kaohsiung Medical University Hospital, Kaohsiung Medical University, Kaohsiung, TaiwanDepartment of Pediatrics, School of Medicine, College of Medicine, Kaohsiung Medical University, Kaohsiung, TaiwanClosure of the ductus arteriosus (DA) involves vasoconstriction and vascular remodeling. Cinaciguat, a soluble guanylyl cyclase (sGC) activator, was reported with vasodilatory and anti-remodeling effects on pulmonary hypertensive vessels. However, its effects on DA are not understood. Therefore, we investigated whether cinaciguat regulated DA patency and examined its underlying mechanisms. In vivo, we found that cinaciguat (10 mg/kg, i.p. at birth) prevented DA closure at 2 h after birth with luminal patency and attenuated intimal thickening. These anti-remodeling effects were associated with enhanced expression of cyclic guanosine monophosphate (cGMP) in DA. Ex vivo, cinaciguat dilated oxygen-induced DA constriction dose-dependently. Such vasodilatory effect was blunted by KT-5823, a PKG inhibitor. In DA smooth muscle cells (DASMCs), we further showed that cinaciguat inhibited angiotensin II (Ang II)-induced proliferation and migration of DASMCs. In addition, cinaciguat inhibited Ang II-induced mitochondrial reactive oxygen species (ROS) production. Finally, Ang II-activated MAPKs and Akt were also inhibited by cinaciguat. In conclusion, cinaciguat prevents postnatal DA closure by vasodilation and anti-remodeling through the cGMP/PKG pathway. The mechanisms underlying anti-remodeling effects include anti-proliferation and anti-migration, with attenuation of mitochondrial ROS production, MAPKs, and Akt signaling. Thus, this study implicates that sGC activation may be a promising novel strategy to regulate DA patency.https://www.frontiersin.org/articles/10.3389/fphys.2021.661171/fullductus arteriosussoluble guanylyl cyclaseremodelingvasoconstrictionvascular smooth muscle
spellingShingle Yu-Chi Hung
Yu-Chi Hung
Yi-Ching Liu
Bin-Nan Wu
Bin-Nan Wu
Bin-Nan Wu
Jwu-Lai Yeh
Jwu-Lai Yeh
Jwu-Lai Yeh
Jwu-Lai Yeh
Jong-Hau Hsu
Jong-Hau Hsu
Cinaciguat Prevents Postnatal Closure of Ductus Arteriosus by Vasodilation and Anti-remodeling in Neonatal Rats
Frontiers in Physiology
ductus arteriosus
soluble guanylyl cyclase
remodeling
vasoconstriction
vascular smooth muscle
title Cinaciguat Prevents Postnatal Closure of Ductus Arteriosus by Vasodilation and Anti-remodeling in Neonatal Rats
title_full Cinaciguat Prevents Postnatal Closure of Ductus Arteriosus by Vasodilation and Anti-remodeling in Neonatal Rats
title_fullStr Cinaciguat Prevents Postnatal Closure of Ductus Arteriosus by Vasodilation and Anti-remodeling in Neonatal Rats
title_full_unstemmed Cinaciguat Prevents Postnatal Closure of Ductus Arteriosus by Vasodilation and Anti-remodeling in Neonatal Rats
title_short Cinaciguat Prevents Postnatal Closure of Ductus Arteriosus by Vasodilation and Anti-remodeling in Neonatal Rats
title_sort cinaciguat prevents postnatal closure of ductus arteriosus by vasodilation and anti remodeling in neonatal rats
topic ductus arteriosus
soluble guanylyl cyclase
remodeling
vasoconstriction
vascular smooth muscle
url https://www.frontiersin.org/articles/10.3389/fphys.2021.661171/full
work_keys_str_mv AT yuchihung cinaciguatpreventspostnatalclosureofductusarteriosusbyvasodilationandantiremodelinginneonatalrats
AT yuchihung cinaciguatpreventspostnatalclosureofductusarteriosusbyvasodilationandantiremodelinginneonatalrats
AT yichingliu cinaciguatpreventspostnatalclosureofductusarteriosusbyvasodilationandantiremodelinginneonatalrats
AT binnanwu cinaciguatpreventspostnatalclosureofductusarteriosusbyvasodilationandantiremodelinginneonatalrats
AT binnanwu cinaciguatpreventspostnatalclosureofductusarteriosusbyvasodilationandantiremodelinginneonatalrats
AT binnanwu cinaciguatpreventspostnatalclosureofductusarteriosusbyvasodilationandantiremodelinginneonatalrats
AT jwulaiyeh cinaciguatpreventspostnatalclosureofductusarteriosusbyvasodilationandantiremodelinginneonatalrats
AT jwulaiyeh cinaciguatpreventspostnatalclosureofductusarteriosusbyvasodilationandantiremodelinginneonatalrats
AT jwulaiyeh cinaciguatpreventspostnatalclosureofductusarteriosusbyvasodilationandantiremodelinginneonatalrats
AT jwulaiyeh cinaciguatpreventspostnatalclosureofductusarteriosusbyvasodilationandantiremodelinginneonatalrats
AT jonghauhsu cinaciguatpreventspostnatalclosureofductusarteriosusbyvasodilationandantiremodelinginneonatalrats
AT jonghauhsu cinaciguatpreventspostnatalclosureofductusarteriosusbyvasodilationandantiremodelinginneonatalrats